Analysts
Coverage
Investec Henderson Crosthwaite |
Meg Geldens |
Tel:020 7597 5039 |
Email: [email protected] |
Investec
Analyst Report (18/06/02)
Click here to download as a pdf. document.
Investec
Analyst Report (10/12/01)
Click here to download as a pdf. document.
INVESTEC
HENDERSON CROSTHWAITE SECURITIES 18 June, 2002
ITE.L
Market Cap: �75m
Price: 28p
ITE - Trading Update
BUY
After a difficult
2 years, it appears we are near a turning point for ITE. The new CEO,
Stephen Warshaw, has been clearing the decks since his arrival 8 months
ago and is re-focusing the group on its core strengths in Russia and CIS.
After PBT of �6.8m in FY2002E, we expect a recovery to �14.0m in FY2003E.
Even considering a normal emerging market discount, the valuation is low.
- Even bearing in
mind an emerging market discount, ITE shares look cheap on 2003 P/E
of 7.6x (8.0x calendarised) and EV/EBITDA of 4.6x (4.7x calendarised).
- It looks as if
the problems will be behind us after this year. New management (Stephen
Warshaw) has nearly completed a rationalisation program and is re- orienting
ITE towards its core strong franchises in Russia and CIS.
- Interims (1HFY02)
showed good top line growth (4.5%), but further goodwill impairments,
� (3.2) m of one-off restructuring costs and repeating higher staff
costs.
- We expect PBT
to recover to �14.0m in FY2003E, driven by absence of one-off costs,
presence of bi-ennial events, increased space selling opportunities
in Russia and re-staging of Turkish events (cancelled in FY2002).
- While exposure
to Russia carries higher risk, it may be beneficial at present as the
economy is relatively strong and ITE's Russian trade shows are trading
strongly.
Performance
Year
End: 30 September |
2000
|
2001
|
2002E
|
2003E
|
2004E
|
Turnover
(£m) |
38.8
|
50.4
|
46.4
|
52.1
|
48.7
|
EBITDA
(£m) |
12.2
|
11.4
|
7.4
|
12.7
|
10.9
|
EBITA
(£m) |
12.6
|
11.4
|
6.1
|
13.3
|
11.5
|
EBIT
(£m) |
32.3%
|
22.6%
|
13.1%
|
25.6%
|
23.5%
|
PBT
(Pre-exceptional) (£m) |
12.6
|
12.4
|
6.8
|
14.0
|
12.2
|
Tax
Rate (%) |
32.5%
|
33.1%
|
39.0%
|
31.0%
|
31.0%
|
EPS
(FRS3) (p) |
3.2
|
-13.5
|
-1.7
|
2.8
|
2.2
|
EPS
(pre-exceptional) (p) |
4.4
|
3.5
|
1.6
|
3.6
|
3.1
|
DPS |
1.5
|
0.5
|
2.4
|
1.5
|
1.5
|
DISCLAIMER
The information and materials presented in this report are provided to
you for information purposes only and are not to be considered as an offer
or solicitation of an offer to sell, buy or subscribe to any financial
instruments. This report is intended for use by professional and business
investors only. This report may not be reproduced in whole or in part
or otherwise, without the consent of Investec Group or one of its affiliates.
The information and opinions expressed in this report have been compiled
from sources believed to be reliable, but, neither Investec, nor any of
its directors, officers, or employees accepts liability for any loss arising
from the use hereof or makes any representation as to its accuracy and
completeness. Investec, and any company or individual connected to it,
including its directors and employees may to the extent permitted by law,
have effected a transaction or have a position or interest in any investment
or any related investments or service recommended in this report. Investec
may, to the extent permitted by law, act upon or use the information or
opinions presented herein, or research or analysis on which they are based
before the material is published. Past performance should not be taken
as an indication or guarantee of future performance, and no representation
or warranty, express or implied is made regarding future performance.
Information, opinions and estimates contained in this report reflect a
judgment at its original date of publication by Investec and are subject
to change. Investec is not agreeing to nor required to update research
commentary and data. Therefore, information may not reflect events occurring
after the date of publication. The value of any securities or financial
instruments mentioned in this report can fall as well as rise. Foreign
currency denominated securities and financial instruments are subject
to fluctuations in exchange rates that may have a positive or adverse
effect on the value, price or income of such securities or financial instruments.
Certain transactions, including those involving futures and options, can
give rise to substantial risk and are not suitable for all investors.
Investec may have issued other reports that are inconsistent with, and
reach different conclusions from, the information presented in this report.
Those reports reflect the different assumptions, views and analytical
methods of the analysts who prepared them. To our readers in the United
Kingdom, this report has been issued by Investec Bank (UK) Limited, a
firm regulated by the Financial Services Authority and is not for distribution
to private customers. To our readers in the Republic of Ireland, this
report is issued in the Republic of Ireland by Investec Bank (UK) Limited
(Irish branch), and Investec Gandon Limited, a firm regulated by the Central
Bank of Ireland. This report is disseminated in South Africa by Investec
Bank Limited, a firm regulated by the South African Reserve Bank, and
in Israel by Investec Clali Bank Limited, and in Switzerland by Investec
Bank (Switzerland) AG. This report is not intended for use or distribution
for US corporates who do not meet the definition of a major US institutional
investor in the United States or for use by any citizen or resident of
the United States.
Investec
henderson crosthwaite securities (a division of investec bank (uk) limited
- regulated by the sfa), and connected companies, their directors, members,
employees, and members of their families may have positions in the securities
mentioned. Investors should be aware that past performance is not necessarily
a guide to future performance and the price of your investment may go
down as well as up.
COPYRIGHT:
INVESTEC HENDERSON CROSTHWAITE SECURITIES. ALL RIGHTS RESERVED.
|